Previous close | 63.03 |
Open | 65.05 |
Bid | 0.00 x 0 |
Ask | 0.00 x 0 |
Day's range | 65.05 - 65.85 |
52-week range | 47.14 - 72.39 |
Volume | |
Avg. volume | 1,887 |
Market cap | 12.708B |
Beta (5Y monthly) | 0.60 |
PE ratio (TTM) | 39.43 |
EPS (TTM) | 1.67 |
Earnings date | N/A |
Forward dividend & yield | 1.09 (1.72%) |
Ex-dividend date | 05 Jul 2023 |
1y target est | N/A |
LUXEMBOURG, April 05, 2024--Regulatory News: Eurofins Scientific SE (Paris:ERF):
LUXEMBOURG, April 03, 2024--Regulatory News: Eurofins Scientific (EUFI.PA), a global leader in bioanalytical testing, announces the closing of its acquisition of Ascend Clinical, LLC ("Ascend"), the largest independent laboratory for kidney dialysis testing in the United States. Founded in 2000, Ascend operates a state-of-the-art laboratory in Sunnyvale, California and employs 170 staff. The company provides highly automated chemistry, hematology, microbiology and virology testing services to di
LUXEMBOURG, March 25, 2024--Regulatory News: Eurofins (Paris:ERF):